Oral lesions in HIV-infected patients, before and after antiretroviral treatment

References

• Naidoo S, Chikte U. Orofacial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 2004; 10:13–18.
   Google Scholar
• Naidoo S, Chikte UME. HIV/AIDS the evolving pandemic in sub-Saharan Africa and its implications for oral health. SADJ 1999; 54: 616–630
   Google Scholar
• Miziara ID, Araujo Filho BC, Weber R. Oral lesions in Brazilian HIV-infected childrenundergoing ART. Int J Pediatric Otorhinolaryngology, 2005: xxx: 1–8
   Google Scholar
• Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle. Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors:A New Face of oral AIDS? AIDS Care STDs 2000; 14: 627–635
   Google Scholar
• Schimdt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA (2000).Decline in the rate of opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29: 336–341
   Google Scholar
• Hamza OJM, Matee MIN, Simon ENM, Kikwilu E, Moshi MJ, Mugusi F, Mita FHM, Verweij PE, van der Ven AJAM. Oral manifestations of HIV infection in children and adults receiving highly active ante-retroviral therapy [ART] in Dar es Salaam, Tanzania. BMC Oral Health 2006; 6:12
   Google Scholar
• Olaniyi OT, Sunday P. Oral manifestation of HIV infection in 36 Nigerian children. J Clin Pediatr Dent 2005; 30: 89–92
   Google Scholar
• Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral maxillofacial surgical clinics. Oral Diseases 2003; 9:317–332
   Google Scholar
• Jonsson N, Zimmerman M, Chidzonga MM, Jonsson K. Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist centre. Cent Afr J Med 1998; 44: 31–34
   Google Scholar
• Ministry of Health and Child Welfare (MOHCW). The HIV&AIDS prevention, care and treatment newsletter 2006; April: 1–8
   Google Scholar
• Roed-Petersen B, Renstrup G. A topographical classification of the oral mucosa suitable for electronic data processing. Its application to 560 leukoplakias. Acta Odontol Scand 1969; 27: 681–695
   Google Scholar
• EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. EC Clearinghouse on oral problems related to HIV infection and WHO Collaborating centre on oral manifestations of the immunodeficiency virus. J Oral Pathol Med 1993; 22: 289–291
   Google Scholar
• Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia as predictors of ART failure in Brazilian HIV- infected patients. Oral Diseases 2006; 12: 402–407
   Google Scholar
• Ramirez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramirez B, Sierra-Madero J. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Clin Infect Dis 2007; 45: 925–932
   Google Scholar
• Tappuni AR, Fleming GJP. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV infected patients: A UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 623–628
   Google Scholar
• Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 299–304
   Google Scholar
• Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and ART in industrialized countries. Adv Dent Res 2006; 19: 57–62
   Google Scholar
• Gaitan Cepeda LA, Ceballos Salobrena A, Lopez Ortega K, Arzate Mora N, Jimenez Soriano Y. Oral lesions and immune reconstitution syndrome in HIV/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence. Med Oral Patol Oral Cir Bucal 2008; 13: E85–93.
   Google Scholar
• Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanicolou IS, Kordossis T. Effect of PI-ART on the prevalence of oral lesions in HIV - 1 infected patients: A Greek Study. Oral Diseases 2004; 10: 145–150
   Google Scholar
• Aquino-Garcia S I, Rivas MA, Ceballos-Salobrena A, Acosta-Gio A E, Gaitan-Cepeda. Oral Lesions in HIV/AIDS Patients Undergoing ART Including Efavirenz. Aids Research Human Retroviruses 2008; 24: 36–45
   Google Scholar
• Umadevi KM, Ranganathan K, Pavithra S, Hemalatha R, Saraswathi TR, Kumarasamy N, Solomon S, Greenspan JS. Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India. J Oral Pathol Med 2007; 36:136–141
   Google Scholar
• Arribas JR, Hernandez-Albujar S, Gonzalez-Garcia JJ, Pena JM, Gonzalez A, Cariedo T, Madero R, Vazquez JJ, Powderly WG. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 2000; 14: 979–985
   Google Scholar
• Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KAAS. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (ART) in South London. J Oral Pathol Med 2002; 31:169–174
   Google Scholar
• Frezzini C, Leao CJ, Porter S. Current trends of HIV disease in the mouth. J Oral Pathol Med 2005; 34: 513–531
   Google Scholar
• Greenspan D, Canchola JA, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 1411–1415
   Google Scholar
• Sroussi HY, Villines D, Epstein J, Alves MC, Alves ME. Oral lesions in HIV-positive dental patients--one more argument for tobacco smoking cessation. Oral Dis 2001; 13:324–328
   Google Scholar
• Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves MEAF, MacPhail LA, Mulligan R, Greenspan JS. Incidence of HIV-1 infected Women: Reduction with ART. J Dent Res 2004; 83: 145–150
   Google Scholar
• Flint SR, Tappuni A, Leigh J, Schmidt-Westhausen AM, MacPhail L. (B3) Markers of immunodeficiency and mechanisms of ART therapy on oral lesions. Adv Dent Res 2006; 19(1): 146–151
   Google Scholar
• Espinosa E, Pefia-Jiménez A, Ormsby CE, Vega-Barrientos R, Reyes-Teran G. Later onset of herpes zoster-associated immune reconstitution inflammatory syndrome. HIV Med. 2009; 10(7): 454–457
   Google Scholar
• Osei-Sekyere B, Karstaedt AS. Immune reconstitution inflammatory syndrome involving the skin. Clin Exp Dermatol 2010; 35(5): 477–481
   Google Scholar
• Meys R, Gotch FM, Bunker CD. Human papi I lomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease? Br J Dermatol 2010; 162(1): 6–11
   Google Scholar